Columbus McKinnon (CMCO) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CMCO Columbus McKinnon

Watchlist

38.560
+1.420+3.82%

Trading Nov 22 15:21 ET

1.11BMarket Cap74.15P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Columbus McKinnon To Go Ex-Dividend On November 8th, 2024 With 0.07 USD Dividend Per Share
Moomoo NewsNov 6 20:00 ET
Columbus McKinnon to Present at the Baird 2024 Global Industrials Conference
PR NewswireNov 6 16:30 ET
Express News | Shares of Machinery Companies Are Trading Higher. Investors May Be Reacting to the US Presidential Election and Its Impact on the Industry
BenzingaNov 6 14:24 ET
There May Be Some Bright Spots In Columbus McKinnon's (NASDAQ:CMCO) Earnings
Simply Wall StNov 6 05:24 ET
Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Stanley Black & Decker (SWK), Columbus Mckinnon (CMCO) and ATI (ATI)
TipRanksNov 5 07:21 ET · Ratings
Insider Purchase: President & CEO of Columbus McKinnon (CMCO) Buys 10,300 Shares
Quiver QuantitativeNov 4 20:09 ET

Comments

Moomoo AI

Feb 5 08:16

Insider's sale of shares at a lower price may suggest belief in the stock's full valuation. However, this is a weak sign and doesn't definitively indicate their view on the stock's value. The lack of insider buying recently and history of sales make us cautious about the stock.

Senior Vice President of Global Product Development & Marketing Mario Ramos Lara Sold A Bunch Of Shares In Columbus McKinnon

Moomoo AI

Jan 4 11:55

Columbus McKinnon's high P/E compared to the market appears justified due to expected earnings growth and potential EPS increase. This is anticipated to strongly support the share price, barring changes in circumstances.

Getting In Cheap On Columbus McKinnon Corporation (NASDAQ:CMCO) Might Be Difficult

Analysts Notebook

May 27, 2022 08:58

Columns Analysts' screen via BofA, JPMorgan, Morgan Stanley, Mizuho and more

BOFA
• $Oscar Health (OSCR.US)$ BofA analyst Kevin Fischbeck downgraded Oscar Health to Neutral from Buy with a price target of $6, down from $12. The analyst sees greater medical loss ratio uncertainty into 2023. The industry is going to have to manage through the expiration of the expanded Affordable Care Act subsidies, Medicaid redeterminations and the result shift within the risk pool making it more difficult to price, Fischb...

Analysts Notebook

May 26, 2022 05:30

Columns Top upgrades and downgrades on 5/26

Upgrades
• $AmerisourceBergen (ABC.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $182 (from $175)
• $Alignment Healthcare (ALHC.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $14 (from $18)
• $Cigna Group (CI.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $300 (from $265)
• $Canadian National Railway (CNI.US)$ : Evercore ISI Upgrades to Outperform from In Line
• $Youdao (DAO.US)$ : Citic Securities Upgrades to Buy from Neut...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

CMCO Columbus McKinnon

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target